Large-scale testing (Phase 3)Looking for participantsNCT04666610
What this trial is testing
Evaluate the Efficacy, Safety, and Tolerability of Brivaracetam as Monotherapy in Patients 2 to 25 Years of Age With Childhood Absence Epilepsy or Juvenile Absence Epilepsy
Who this might be right for
Childhood Absence EpilepsyJuvenile Absence Epilepsy
UCB Biopharma SRL 160